ID
13726
Description
A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old; ODM derived from: https://clinicaltrials.gov/show/NCT00927498
Link
https://clinicaltrials.gov/show/NCT00927498
Keywords
Versions (1)
- 3/1/16 3/1/16 -
Copyright Holder
CC BY-NC 3.0
Uploaded on
March 1, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Myeloid Leukemia NCT00927498
Eligibility Acute Myeloid Leukemia NCT00927498
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
m3-aml
Data type
boolean
Alias
- UMLS CUI [1]
- C0023487
Description
aml following previously know myeloproliferative syndrome.
Data type
boolean
Alias
- UMLS CUI [1]
- C0280449
- UMLS CUI [2,1]
- C1443043
- UMLS CUI [2,2]
- C0332152
Description
known central nervous system involvement.
Data type
boolean
Alias
- UMLS CUI [1]
- C0449389
Description
uncontrolled infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
other active malignancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Similar models
Eligibility Acute Myeloid Leukemia NCT00927498
- StudyEvent: Eligibility
C0332155 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C3831118 (UMLS CUI [2])
C1443043 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])